MBIO:NASDAQ
Mustang Bio Inc
0,41 USD
0,00%
(0,00) 1D
0,41 USD
arrow_downward
-1,31% (-0,0054)todayPre-market
Closed: 12-окт., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Mkt. cap
3,13 млн
Avg. vol.
32,47 миң
Volume
288,00
52-wk high
1,69 USD
52-wk low
0,38 USD
EPS
-0,46 USD
Beta
2,09
Shares outstanding
6,73 млн
No. of employees
4
Mkt. cap
3,13 млн
Avg. vol.
32,47 миң
Volume
288,00
52-wk high
1,69 USD
52-wk low
0,38 USD
EPS
-0,46 USD
Beta
2,09
Shares outstanding
6,73 млн
No. of employees
4
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 апта мурун
MBIO Q4 2024 Earnings: Wider-Than-Expected Loss Per Share Dominates the Quarter - Profit Margin Analysis
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersУолтем, Массачусетс, Америка Кошмо Штаттары
Sector-
Websitemustangbio.com